Phoenix bioscience firm raises $8.9M in venture capital for genetic profiling test
The company's sequencing test identifies cancer tumors to personalize a patient's treatment plan.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Angela Gonzales Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Genetics | Health Management | Venture Capital